Navidea Biopharmaceuticals Inc (OP: NAVB )

0.0010 +0.0005 (+100.00%)
Streaming Delayed Price Updated: 10:36 AM EST, Nov 8, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
May 08, 2003
Form ARS
Source: SEC/Edgar
May 05, 2003
Form DEF 14A
Source: SEC/Edgar
May 04, 2003
Form PRER14A
Source: SEC/Edgar
April 22, 2003
Form PRE 14A
Source: SEC/Edgar
April 16, 2003
Form 8-K
Source: SEC/Edgar
April 08, 2003
Form 424B3
Source: SEC/Edgar
March 31, 2003
Form 10KSB
Source: SEC/Edgar
March 30, 2003
Form SC 13G/A
Source: SEC/Edgar
February 18, 2003
Form 424B3
Source: SEC/Edgar
November 20, 2002
Form 10QSB
Source: SEC/Edgar
November 13, 2002
Form 424B3
Source: SEC/Edgar
September 30, 2002
Form 424B3
Source: SEC/Edgar
September 09, 2002
Form 10QSB
Source: SEC/Edgar
August 12, 2002
Form SB-2
Source: SEC/Edgar
June 27, 2002
Form 424B3
Source: SEC/Edgar
May 14, 2002
Form 10QSB
Source: SEC/Edgar
May 14, 2002
Form DEF 14A
Source: SEC/Edgar
May 09, 2002
Form 424B3
Source: SEC/Edgar
May 02, 2002
Form PRE 14A
Source: SEC/Edgar
April 25, 2002
Form SB-2
Source: SEC/Edgar
March 21, 2002
Form 10KSB
Source: SEC/Edgar
March 07, 2002
Form SC 13G
Source: SEC/Edgar
February 13, 2002
Form 8-K
Source: SEC/Edgar
January 07, 2002
Form 8-K
Source: SEC/Edgar
December 02, 2001
Form 10QSB
Source: SEC/Edgar
November 13, 2001
Form 8-K
Source: SEC/Edgar
September 11, 2001
Form 10QSB
Source: SEC/Edgar
August 13, 2001
Form 10QSB
Source: SEC/Edgar
May 10, 2001
Form DEF 14A
Source: SEC/Edgar
May 09, 2001
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.